SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 11076.50 millions for the June 2023 quarter as against Rs. 14952.50 millions during the year-ago period.The company reported a drastic decline of -94.36% in the quarter ended June 2023 to Rs. 130.70  millions from Rs. 2316.10 millions  .Operating profit for the quarter ended June 2023 decreased to 1345.90 millions as compared to 4211.10 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 11076.50 14952.50 -25.92 11076.50 14952.50 -25.92 57734.50 47070.40 22.66
Other Income 67.10 29.30 129.01 67.10 29.30 129.01 159.50 215.50 -25.99
PBIDT 1345.90 4211.10 -68.04 1345.90 4211.10 -68.04 14977.10 13067.50 14.61
Interest 334.70 275.00 21.71 334.70 275.00 21.71 1457.00 958.60 51.99
PBDT 1011.20 3936.10 -74.31 1011.20 3936.10 -74.31 13520.10 12108.90 11.65
Depreciation 838.70 660.00 27.08 838.70 660.00 27.08 3005.80 2354.80 27.65
PBT 172.50 3276.10 -94.73 172.50 3276.10 -94.73 10514.30 9754.10 7.79
TAX 41.80 960.00 -95.65 41.80 960.00 -95.65 2910.50 2253.20 29.17
Deferred Tax -22.50 -69.80 -67.77 -22.50 -69.80 -67.77 202.70 -61.00 -432.30
PAT 130.70 2316.10 -94.36 130.70 2316.10 -94.36 7603.80 7500.90 1.37
Equity 1077.30 1074.70 0.24 1077.30 1074.70 0.24 1077.30 1074.70 0.24
PBIDTM(%) 12.15 28.16 -56.86 12.15 28.16 -56.86 25.94 27.76 -6.56

Laurus Labs Share Price

1113.50 -15.30 (-1.36%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×